Lilly licenses non-opioid pain therapeutic from Centrexion

CNTX-0290 is currently undergoing Phase I clinical trials as a potential non-opioid therapy to treat chronic pain. Credit: newsong from Pixabay.



  • Lilly licences non-opioid pain therapeutic from Centrexion